Latest News

 

Tran Receives AABB Top Poster Award

10/12/2018

Dr. Johnson Tran, of Dr. Jackman's lab, received the award for Top Poster at the annual AABB Conference held in Boston. The presentation abstract titled, “Pathogen Reduction of Platelet Rich Plasma Abrogates T Cell Alloresponse in Mice” demonstrated how allogeneic CD4+ and CD8+ T cell activation and effector responses were significantly diminished after pathogen reduction with UV+R treatment. Read more about the AABB Conference here.

CHIKV inhibited by neutralizing antibodies

9/25/2018

In the recent issue of Cell Host & Microbe, Dr. Jin et al report that some anti-CHIKV neutralizing mAbs inhibit the budding step of the CHIKV replication cycle by inducing crosslinking of viral GPs at the PM. It is demonstrated that anti-CHIKV neutralizing mAbs crosslink viral GPs at the PM of infected cells, preventing envelopment of nucleocapsids and causing the accumulation of arrested nucleocapsids in the cytosol. Watch here.

Roubinian Receives ECDHM Best Oral Abstract Award

9/7/2018

Dr. Roubinian receives the award for Best Oral Abstract Presentation at the European Donor Health and Outcomes Congress in Copenhagen.   The presentation abstract titled, “Influence of Donor, Component, and Recipient Factors on Efficacy of Erythrocyte Transfusions” examined the role of blood donor, component and transfusion recipient factors on hemoglobin increments following red blood cell transfusion. Read more about the ECDHM Congress here.

Busch granted the 2018 IPFA Award

5/17/2018

Dr. Busch received the first annual IPFA Award at the 25th International Workshop held in Athens, Greece to recognize his exceptional scientific contributions to the study and prevention of Transfusion Transmitted Infections. Read more about the award and the selection process here.

Busch granted the 2018 ISBT Presidential Award

2/13/2018

The International Society of Blood Transfusion (ISBT) has recently announced that the Foundation of Transfusion Medicine has granted the ISBT Presidential Award to Dr. Michael Busch, the Director of BSRI. This award is granted to those who have made eminent contributions to transfusion medicine through original research, the practice of transfusion therapy and significant service contributions to the field. Read more about the award and the selection process here.

Protective Immune Responses for Ebola survivors 40 years later

12/13/2017

In collaboration with UCLA, NIH and scientists within the Democratic Republic of Congo (DRC), we have recently demonstrated that survivors of the first recorded outbreak of Ebola virus maintain potent protective immune responses over 40 years after infection. The BSRI Simmons Lab performed serological analysis for evidence of Ebola infection. Multiple serological assays such as ELISA were utilized for multiple virus proteins and algorithms for determining reactivity based on more than one assay. Read more about the serological assays developed for Ebola here. 

Displaying results 13-18 (of 35)
 1 2 3 4 5 6